BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31838895)

  • 1. Multifunctional hybrid sulfonamides as novel therapeutic agents for Alzheimer's disease.
    Swetha R; Kumar D; Gupta SK; Ganeshpurkar A; Singh R; Gutti G; Kumar D; Jana S; Krishnamurthy S; Singh SK
    Future Med Chem; 2019 Dec; 11(24):3161-3178. PubMed ID: 31838895
    [No Abstract]   [Full Text] [Related]  

  • 2. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
    Manral A; Saini V; Meena P; Tiwari M
    Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease.
    Wichur T; Więckowska A; Więckowski K; Godyń J; Jończyk J; Valdivieso ÁDR; Panek D; Pasieka A; Sabaté R; Knez D; Gobec S; Malawska B
    Eur J Med Chem; 2020 Feb; 187():111916. PubMed ID: 31812794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
    Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.
    Osman W; Mohamed T; Sit VM; Vasefi MS; Beazely MA; Rao PP
    Chem Biol Drug Des; 2016 Nov; 88(5):710-723. PubMed ID: 27282589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfonamides as multifunctional agents for Alzheimer's disease.
    Bag S; Tulsan R; Sood A; Cho H; Redjeb H; Zhou W; LeVine H; Török B; Török M
    Bioorg Med Chem Lett; 2015 Feb; 25(3):626-30. PubMed ID: 25537270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional scutellarin-rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer's disease.
    Sang Z; Li Y; Qiang X; Xiao G; Liu Q; Tan Z; Deng Y
    Bioorg Med Chem; 2015 Feb; 23(4):668-80. PubMed ID: 25614117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
    Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
    Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Shi J; Liu W; Tan Z
    Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids as Multifunctional Drug Candidates against Alzheimer's Disease.
    Fu Y; Mu Y; Lei H; Wang P; Li X; Leng Q; Han L; Qu X; Wang Z; Huang X
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27727187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.
    Wu M; Ma J; Ji L; Wang M; Han J; Li Z
    Eur J Med Chem; 2019 Sep; 177():198-211. PubMed ID: 31136894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
    Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
    Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
    Jalili-Baleh L; Nadri H; Moradi A; Bukhari SNA; Shakibaie M; Jafari M; Golshani M; Homayouni Moghadam F; Firoozpour L; Asadipour A; Emami S; Khoobi M; Foroumadi A
    Eur J Med Chem; 2017 Oct; 139():280-289. PubMed ID: 28803044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease.
    Tripathi A; Choubey PK; Sharma P; Seth A; Tripathi PN; Tripathi MK; Prajapati SK; Krishnamurthy S; Shrivastava SK
    Eur J Med Chem; 2019 Dec; 183():111707. PubMed ID: 31561043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
    Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
    Zha GF; Zhang CP; Qin HL; Jantan I; Sher M; Amjad MW; Hussain MA; Hussain Z; Bukhari SN
    Bioorg Med Chem; 2016 May; 24(10):2352-9. PubMed ID: 27083471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multifunctional therapeutic approach: Synthesis, biological evaluation, crystal structure and molecular docking of diversified 1H-pyrazolo[3,4-b]pyridine derivatives against Alzheimer's disease.
    Umar T; Shalini S; Raza MK; Gusain S; Kumar J; Seth P; Tiwari M; Hoda N
    Eur J Med Chem; 2019 Aug; 175():2-19. PubMed ID: 31055149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer's disease.
    Singh YP; Tej GNVC; Pandey A; Priya K; Pandey P; Shankar G; Nayak PK; Rai G; Chittiboyina AG; Doerksen RJ; Vishwakarma S; Modi G
    Eur J Med Chem; 2020 Jul; 198():112257. PubMed ID: 32375073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Piperazinediones as dual inhibitor for treatment of Alzheimer's disease.
    Kumar D; Gupta SK; Ganeshpurkar A; Gutti G; Krishnamurthy S; Modi G; Singh SK
    Eur J Med Chem; 2018 Apr; 150():87-101. PubMed ID: 29524731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
    Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
    Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.